+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopharmaceutical Bioseparation Systems Market - Global Forecast 2026-2032- Product Image
Biopharmaceutical Bioseparation Systems Market - Global Forecast 2026-2032- Product Image
Sale

Biopharmaceutical Bioseparation Systems Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010879
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biopharmaceutical Bioseparation Systems Market is projected to reach USD 16.87 Billion in 2026. It is expected to continue growing at a CAGR of 9.64%, reaching USD 29.39 Billion by 2032.

Biopharmaceutical Bioseparation Systems: Executive Overview

Biopharmaceutical bioseparation systems support the purification, concentration, clarification, and polishing of biologic products, including therapeutic proteins, vaccines, cell-based products, and nucleic-acid medicines. The field encompasses chromatography, filtration, centrifugation, membrane-based processing, and integrated single-use technologies. Demand is closely linked to biologics development, manufacturing complexity, regulatory expectations, and the need for reproducible product quality.

Manufacturing Complexity Is Reshaping Bioseparation Workflows

Biomanufacturers are adapting separation strategies to more diverse product types, higher titers, intensified processing, and tighter contamination-control requirements. Process analytical technology, continuous processing, single-use equipment, and modular facility designs are encouraging more connected workflows. At the same time, manufacturers must balance throughput, yield, resin and membrane performance, validation requirements, supply continuity, and the practical constraints of existing facilities.

Artificial Intelligence Is Strengthening Process Decisions and Control

Artificial intelligence is being applied to process development, anomaly detection, predictive maintenance, experimental design, and interpretation of high-dimensional process data. In bioseparation, machine-learning models can help identify relationships among feed variability, operating conditions, impurity profiles, and product quality attributes. Adoption remains dependent on data quality, model explainability, cybersecurity, validation, and alignment with good manufacturing practice; AI is therefore most useful when integrated with established process knowledge and human oversight.

Regional Insights: Different Production Bases, Shared Quality Priorities

North America combines advanced biologics manufacturing, strong research capacity, and extensive adoption of automated and single-use platforms. Europe emphasizes regulatory control, sustainability, process intensification, and cross-border manufacturing coordination. Asia-Pacific is expanding biomanufacturing capabilities and technology adoption, with varied maturity across markets. Latin America is strengthening local production and technology access while managing infrastructure and procurement constraints. The Middle East is developing life-science capacity and strategic manufacturing capabilities, whereas Africa is focused on improving pharmaceutical resilience, technical skills, and access to reliable processing infrastructure.

Group Insights: Trade, Regulation, and Industrial Policy Shape Adoption

ASEAN markets present a mix of emerging manufacturing hubs and import-dependent systems, making workforce development, technology transfer, and regional supply coordination important. BRICS economies are pursuing greater domestic biopharmaceutical capability while facing differing regulatory and infrastructure conditions. The European Union benefits from coordinated regulatory structures and a strong scientific base, with sustainability and supply resilience remaining important priorities. G7 countries generally support high levels of automation, quality systems, and advanced research. GCC countries are investing in healthcare and industrial diversification, while NATO members reflect varied but significant demand for resilient pharmaceutical supply chains and secure production capabilities.

Country Insights: Capabilities Vary Across Established and Emerging Hubs

The United States and Canada maintain sophisticated bioprocessing ecosystems and strong demand for scalable, compliant separation technologies. Germany, France, Italy, Spain, and the United Kingdom combine established pharmaceutical expertise with continued attention to process efficiency, sustainability, and regulatory compliance. Japan and South Korea emphasize precision manufacturing, automation, and quality assurance. China and India are expanding biologics production, domestic technology capabilities, and skilled workforces. Australia supports research-led biomanufacturing and specialized production. Brazil and Mexico are strengthening regional pharmaceutical capacity, although infrastructure, procurement, and technology access can differ by application and facility.

Priorities for Leaders: Build Flexible, Data-Ready Separation Operations

Industry leaders should design separation platforms around product-specific needs while preserving modularity for future process changes. They should qualify multiple critical inputs where feasible, establish risk-based supplier and inventory strategies, and invest in automation that improves traceability without creating validation bottlenecks. Data standards, interoperable systems, and disciplined process development can improve scale-up decisions and support responsible AI use. Leaders should also develop operator expertise, assess sustainability across water, energy, and consumables, and engage regulators early when introducing continuous, single-use, or digitally enabled workflows.

Research Methodology: Evidence-Based Assessment of the Bioseparation Landscape

This executive summary uses a structured review of the supplied market scope and the operating factors that shape biopharmaceutical bioseparation systems. The assessment organizes evidence by technology function, manufacturing application, regulatory and quality considerations, digital adoption, supply-chain conditions, and geographic context. Regional, group, and country narratives are presented qualitatively, with emphasis on documented industry dynamics rather than estimates, market sizing, shares, or forecasts.

Conclusion: Integration and Resilience Will Define Bioseparation Progress

Biopharmaceutical bioseparation is moving toward more integrated, automated, flexible, and data-enabled manufacturing. Success will depend not only on separation performance, but also on validated control strategies, reliable supply, skilled personnel, sustainability, and the ability to adapt platforms across modalities. Organizations that combine robust process fundamentals with selective digital innovation will be better positioned to improve consistency, manage complexity, and support resilient biologics production.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biopharmaceutical Bioseparation Systems Market, by Product Type
7.1. Introduction
7.2. Centrifugation Systems
7.2.1. Decanter Centrifuge Systems
7.2.2. Disc Stack Centrifuge Systems
7.2.3. Tubular Bowl Centrifuge Systems
7.3. Chromatography Systems
7.3.1. Affinity Chromatography
7.3.1.1. Immobilized Metal Affinity Chromatography
7.3.1.2. Lectin Affinity Chromatography
7.3.1.3. Protein A Affinity Chromatography
7.3.2. Hydrophobic Interaction Chromatography
7.3.3. Ion Exchange Chromatography
7.3.4. Mixed-Mode Chromatography
7.3.5. Size Exclusion Chromatography
7.4. Membrane Filtration Systems
7.4.1. Ultrafiltration Systems
7.4.2. Microfiltration Systems
7.4.3. Nanofiltration Systems
8. Biopharmaceutical Bioseparation Systems Market, by Operation Mode
8.1. Introduction
8.2. Batch Processing
8.3. Continuous Processing
8.3.1. Multi-Column Chromatography
8.3.2. Perfusion Processing
9. Biopharmaceutical Bioseparation Systems Market, by Material Format
9.1. Introduction
9.2. Multi-Use
9.3. Single-Use
9.3.1. Gamma-Irradiated Flow Paths
9.3.2. Presterilized Assemblies
10. Biopharmaceutical Bioseparation Systems Market, by Application
10.1. Introduction
10.2. Cell Clarification
10.3. Polishing & Final Purification
10.4. Protein Purification
10.4.1. Enzyme Purification
10.4.2. Monoclonal Antibodies
10.4.3. Peptide Purification
10.4.4. Recombinant Protein Purification
10.5. Vaccine Production
10.6. Virus Purification
11. Biopharmaceutical Bioseparation Systems Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Biopharmaceutical Companies
11.4. Bioservices
11.5. Contract Manufacturing Organizations
12. Biopharmaceutical Bioseparation Systems Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. Europe
12.4. North America
12.5. Latin America
12.6. Middle East
12.7. Africa
13. Biopharmaceutical Bioseparation Systems Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. European Union
13.5. BRICS
13.6. ASEAN
13.7. GCC
14. Biopharmaceutical Bioseparation Systems Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. Japan
14.6. India
14.7. United Kingdom
14.8. Brazil
14.9. Canada
14.10. Mexico
14.11. France
14.12. South Korea
14.13. Australia
14.14. Russia
14.15. Spain
14.16. Italy
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Danaher Corporation
16.2. Thermo Fisher Scientific Inc.
16.3. Merck KGaA
16.4. Sartorius AG
16.5. Asahi Kasei Corporation
16.6. Agilent Technologies, Inc.
16.7. Waters Corporation
16.8. GEA Group Aktiengesellschaft
16.9. Bio-Rad Laboratories, Inc.
16.10. Shimadzu Corporation
16.11. Tosoh Bioscience LLC
16.12. Repligen Corporation
16.13. Revvity, Inc.
16.14. Alfa Laval AB
16.15. Astrea Bioseparations Group by Biotage AB
16.16. GL Sciences Inc.
16.17. Flottweg SE
16.18. Restek Corporation
16.19. Alfa Wassermann, Inc.
16.20. AnteoTech Ltd
16.21. Critical Process Filtration, Inc.
16.22. Daicel Corporation
16.23. Ecolab Inc.
16.24. Gilson Incorporated
16.25. Hitachi, Ltd.
16.26. JASCO Corporation
16.27. KNAUER Wissenschaftliche Geräte GmbH
16.28. Tecan Trading AG
16.29. YMC CO., LTD.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Biopharmaceutical Bioseparation Systems Market, Years Considered for the Study
FIGURE 2. Global Biopharmaceutical Bioseparation Systems Market, Research Design
FIGURE 3. Global Biopharmaceutical Bioseparation Systems Market, Research Framework
FIGURE 4. Global Biopharmaceutical Bioseparation Systems Market, Data Triangulation
FIGURE 5. Global Biopharmaceutical Bioseparation Systems Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2025 vs 2032 (%)
FIGURE 9. Global Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2025 vs 2032 (%)
FIGURE 11. Global Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biopharmaceutical Bioseparation Systems Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Biopharmaceutical Bioseparation Systems Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biopharmaceutical Bioseparation Systems Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Biopharmaceutical Bioseparation Systems Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biopharmaceutical Bioseparation Systems Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Biopharmaceutical Bioseparation Systems Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Biopharmaceutical Bioseparation Systems Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Biopharmaceutical Bioseparation Systems Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Biopharmaceutical Bioseparation Systems Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Biopharmaceutical Bioseparation Systems Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Biopharmaceutical Bioseparation Systems Market Segmentation & Coverage
TABLE 2. Global Biopharmaceutical Bioseparation Systems Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Centrifugation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Centrifugation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Centrifugation Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Decanter Centrifuge Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Decanter Centrifuge Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Decanter Centrifuge Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Disc Stack Centrifuge Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Disc Stack Centrifuge Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Disc Stack Centrifuge Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Tubular Bowl Centrifuge Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Tubular Bowl Centrifuge Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Tubular Bowl Centrifuge Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Chromatography Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Chromatography Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Chromatography Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Affinity Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Affinity Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Affinity Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Immobilized Metal Affinity Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Immobilized Metal Affinity Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Immobilized Metal Affinity Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Lectin Affinity Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Lectin Affinity Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Lectin Affinity Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Protein A Affinity Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Protein A Affinity Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Protein A Affinity Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Hydrophobic Interaction Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Hydrophobic Interaction Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Hydrophobic Interaction Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Ion Exchange Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Ion Exchange Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Ion Exchange Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Mixed-Mode Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Mixed-Mode Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Mixed-Mode Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Size Exclusion Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Size Exclusion Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Size Exclusion Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Membrane Filtration Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Membrane Filtration Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Membrane Filtration Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Ultrafiltration Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Ultrafiltration Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Ultrafiltration Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Microfiltration Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Microfiltration Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Microfiltration Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Nanofiltration Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Nanofiltration Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Nanofiltration Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 56. Global Batch Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Batch Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Batch Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Continuous Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Continuous Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Continuous Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Multi-Column Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Multi-Column Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Multi-Column Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Perfusion Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Perfusion Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Perfusion Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 69. Global Multi-Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Multi-Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Multi-Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Single-Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Single-Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Single-Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Gamma-Irradiated Flow Paths Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Gamma-Irradiated Flow Paths Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Gamma-Irradiated Flow Paths Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Presterilized Assemblies Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Presterilized Assemblies Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Presterilized Assemblies Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Global Cell Clarification Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Cell Clarification Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Cell Clarification Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Polishing & Final Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Polishing & Final Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Polishing & Final Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Protein Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Protein Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Protein Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Enzyme Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Enzyme Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Enzyme Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Peptide Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Peptide Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Peptide Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Recombinant Protein Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Recombinant Protein Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Recombinant Protein Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Vaccine Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Vaccine Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Vaccine Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Virus Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Virus Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Virus Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Biopharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Biopharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Biopharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Bioservices Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Bioservices Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Bioservices Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Biopharmaceutical Bioseparation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. Europe Biopharmaceutical Bioseparation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Europe Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. Europe Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 139. Europe Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 140. Europe Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 141. Europe Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 142. Europe Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 143. Europe Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 144. Europe Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 145. Europe Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 146. Europe Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Europe Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 148. Europe Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. North America Biopharmaceutical Bioseparation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. North America Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. North America Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 152. North America Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 153. North America Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 154. North America Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 155. North America Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 156. North America Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 157. North America Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 158. North America Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 159. North America Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. North America Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 161. North America Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 165. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 166. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 167. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 168. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 169. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 170. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 171. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 172. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. Latin America Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 174. Latin America Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 178. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 179. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 180. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 181. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 182. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 183. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 184. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 185. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Middle East Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 187. Middle East Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Africa Biopharmaceutical Bioseparation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Africa Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. Africa Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 191. Africa Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 192. Africa Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 193. Africa Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 194. Africa Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 195. Africa Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 196. Africa Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 197. Africa Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 198. Africa Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Africa Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 200. Africa Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Global Biopharmaceutical Bioseparation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. NATO Biopharmaceutical Bioseparation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. NATO Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. NATO Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 205. NATO Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 206. NATO Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 207. NATO Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 208. NATO Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 209. NATO Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 210. NATO Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 211. NATO Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 212. NATO Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. NATO Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 214. NATO Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. G7 Biopharmaceutical Bioseparation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. G7 Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. G7 Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 218. G7 Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 219. G7 Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 220. G7 Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 221. G7 Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 222. G7 Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 223. G7 Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 224. G7 Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 225. G7 Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. G7 Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 227. G7 Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. European Union Biopharmaceutical Bioseparation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. European Union Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. European Union Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 231. European Union Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 232. European Union Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 233. European Union Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 234. European Union Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 235. European Union Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 236. European Union Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 237. European Union Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 238. European Union Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. European Union Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 240. European Union Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 244. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 245. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 246. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 247. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 248. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 249. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 250. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 251. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. BRICS Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 253. BRICS Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 257. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 258. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 259. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 260. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 261. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 262. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 263. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 264. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 266. ASEAN Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. GCC Biopharmaceutical Bioseparation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. GCC Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 269. GCC Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 270. GCC Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 271. GCC Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 272. GCC Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 273. GCC Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 274. GCC Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 275. GCC Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 276. GCC Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 277. GCC Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. GCC Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 279. GCC Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. Global Biopharmaceutical Bioseparation Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 281. United States Biopharmaceutical Bioseparation Systems Market Size, 2017-2032 (USD Million)
TABLE 282. United States Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. United States Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 284. United States Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 285. United States Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 286. United States Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 287. United States Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 288. United States Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 289. United States Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 290. United States Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 291. United States Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. United States Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 293. United States Biopharmaceutical Bioseparation Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. China Biopharmaceutical Bioseparation Systems Market Size, 2017-2032 (USD Million)
TABLE 295. China Biopharmaceutical Bioseparation Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 296. China Biopharmaceutical Bioseparation Systems Market Size, by Centrifugation Systems, 2017-2032 (USD Million)
TABLE 297. China Biopharmaceutical Bioseparation Systems Market Size, by Chromatography Systems, 2017-2032 (USD Million)
TABLE 298. China Biopharmaceutical Bioseparation Systems Market Size, by Affinity Chromatography, 2017-2032 (USD Million)
TABLE 299. China Biopharmaceutical Bioseparation Systems Market Size, by Membrane Filtration Systems, 2017-2032 (USD Million)
TABLE 300. China Biopharmaceutical Bioseparation Systems Market Size, by Operation Mode, 2017-2032 (USD Million)
TABLE 301. China Biopharmaceutical Bioseparation Systems Market Size, by Continuous Processing, 2017-2032 (USD Million)
TABLE 302. China Biopharmaceutical Bioseparation Systems Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 303. China Biopharmaceutical Bioseparation Systems Market Size, by Single-Use, 2017-2032 (USD Million)
TABLE 304. China Biopharmaceutical Bioseparation Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. China Biopharmaceutical Bioseparation Systems Market Size, by Protein Purification, 2017-2032 (USD Million)
TABLE 306. C

Companies Mentioned

  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Sartorius AG
  • Asahi Kasei Corporation
  • Agilent Technologies, Inc.
  • Waters Corporation
  • GEA Group Aktiengesellschaft
  • Bio-Rad Laboratories, Inc.
  • Shimadzu Corporation
  • Tosoh Bioscience LLC
  • Repligen Corporation
  • Revvity, Inc.
  • Alfa Laval AB
  • Astrea Bioseparations Group by Biotage AB
  • GL Sciences Inc.
  • Flottweg SE
  • Restek Corporation
  • Alfa Wassermann, Inc.
  • AnteoTech Ltd
  • Critical Process Filtration, Inc.
  • Daicel Corporation
  • Ecolab Inc.
  • Gilson Incorporated
  • Hitachi, Ltd.
  • JASCO Corporation
  • KNAUER Wissenschaftliche Geräte GmbH
  • Tecan Trading AG
  • YMC CO., LTD.

Related Topics

Related Reports

Biopharmaceutical Bioseparation Systems - Global Strategic Business Report - Product Image

Biopharmaceutical Bioseparation Systems - Global Strategic Business Report

  • Report
  • 360 Pages
  • Global
From
Filtration Market (Focus on Biologics Manufacturing): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Filtration, Type of Filter, Type of Assembly, Company Size and Key Geographical Regions - Product Image

Filtration Market (Focus on Biologics Manufacturing): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Filtration, Type of Filter, Type of Assembly, Company Size and Key Geographical Regions

  • Report
  • 165 Pages
  • Global
From
Biopharmaceuticals Manufacturing Consumables Testing Market - Global Forecast 2026-2032 - Product Image

Biopharmaceuticals Manufacturing Consumables Testing Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Biopharmaceutical Processing Equipment & Consumables Market - Global Forecast 2026-2032 - Product Image

Biopharmaceutical Processing Equipment & Consumables Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Hollow Fiber Filtration - Global Strategic Business Report - Product Image

Hollow Fiber Filtration - Global Strategic Business Report

  • Report
  • 482 Pages
  • Global
From

About the Market

In biotechnology, bioseparation systems are crucial for the purification and analysis of bio-molecules such as proteins, DNA, and antibodies that are used in various biopharmaceutical applications. These systems employ a range of techniques like chromatography, centrifugation, filtration, and electrophoresis to isolate specific biological components from complex mixtures. The demand for these systems is driven by the need for therapeutically and diagnostically relevant biomolecules with high purity and yield. The field is marked by continuous advancement to enhance efficiency, scalability, and cost-effectiveness and to cater to the stringent regulatory standards for biopharmaceutical production. Innovations in the domain often revolve around improving selectivity and reducing processing time. Some notable players in the biopharmaceutical bioseparation systems market include GE Healthcare (now part of Danaher Corporation), Merck KGaA, Thermo Fisher Scientific, and Sartorius Stedim Biotech. These companies provide a range of bioseparation products and services, helping to drive advancements in the preparation of biological products. Each company typically engages in research and development to bring forward innovations in separation technologies that aim to meet the evolving needs of the biopharmaceutical industry. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.